Detalles de la búsqueda
1.
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study.
BMC Cancer
; 22(1): 915, 2022 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-35999527
2.
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Oncol
; 22(10): 1438-1447, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34499874
3.
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority Study.
Oncologist
; 26(10): e1854-e1861, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34101934
4.
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases.
J Transl Med
; 13: 130, 2015 Apr 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-25903963
5.
Redetermination of PD-L1 expression after chemio-radiation in locally advanced PDL1 negative NSCLC patients: retrospective multicentric analysis.
Front Oncol
; 14: 1325249, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357196
6.
Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience.
Diagnostics (Basel)
; 14(10)2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38786322
7.
Changes in the Histology of Lung Cancer in Northern Italy: Impact on Incidence and Mortality.
Cancers (Basel)
; 15(12)2023 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370797
8.
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study).
Sci Rep
; 13(1): 1257, 2023 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690734
9.
Salvage Surgery After First-Line Alectinib for Locally-Advanced/Metastatic ALK-Rearranged NSCLC: Pathological Response and Perioperative Results.
Clin Lung Cancer
; 24(5): 467-473, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37061413
10.
Transcription regulators and ultra-rare and other rare translocation-related sarcomas treated with trabectedin: A proof of principle from a post-hoc analysis.
Front Oncol
; 12: 1042479, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36568164
11.
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.
Cancers (Basel)
; 13(5)2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33801399
12.
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study.
Cancers (Basel)
; 12(10)2020 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33065998
13.
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia.
Biology (Basel)
; 9(8)2020 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32707770
14.
First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status.
Eur J Cancer
; 130: 155-167, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32220780
15.
Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.
PLoS One
; 13(4): e0196350, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29689091
16.
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female Power.
World Neurosurg
; 112: e342-e347, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29337169
17.
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial.
J Clin Oncol
; 35(12): 1281-1287, 2017 Apr 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-28135143
18.
Severe Cushing's syndrome related to a small pulmonary carcinoid with widespread dissemination.
Intern Med
; 54(5): 477-80, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25758073
19.
Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer: treatment rationale and protocol design of the GOIRC-AIFA FARM6PMFJM trial.
Clin Lung Cancer
; 16(1): 67-70, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25450879
20.
Folfox 2 regimen in heavily pretreated patients with advanced colorectal cancer.
Tumori
; 88(4): 270-2, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12400974